BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukemia
,
Retina
,
Personalized medicine
,
Fluoxetine
,
rs2300478
,
PDX1
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Proteasome subunit beta type 9
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Spleen
Tonsil
Whole blood
Natural killer cell of peripheral blood
Small intestine
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Ulceration of intestine
Disorder of lymph node
Antiphospholipid syndrome
Body temperature finding
Bacterial sepsis of newborn
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
perfluorodecanoic acid
Methomyl
Selenium
cyclonite
TGFB2 protein, human
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NBDY
SAR1A
RPL35
TDG
NOVA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Gene expressing changes in zebrafish (Danio rerio) with acute RDX exposure
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
OMIM - Autoinflammation
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Proteasome subunit beta type 9
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ